Hyperglycemia and hyperglucagonemia following neurotensin administration.
D000313:Adrenal Medulla / Q000502:physiology; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005934:Glucagon / Q000097:blood*; D006943:Hyperglycemia / Q000139:chemically induced*; D007031:Hypothalamus; D007269:Injections, Intra-Arterial; D007276:Injections, Intraventricular; D007328:Insulin / Q000097:blood; D008297:Male; D009419:Nerve Tissue Proteins / Q000008:administration & dosage; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013004:Somatostatin / Q000494:pharmacology
D007328:Insulin; D009419:Nerve Tissue Proteins; D013004:Somatostatin; D005934:Glucagon; D011433:Propranolol; D010646:Phentolamine